14,819 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Woodward Diversified Capital LLC

Woodward Diversified Capital LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 14,819 shares of the company's stock, valued at approximately $860,000.

A number of other large investors have also recently bought and sold shares of DOCS. Allworth Financial LP grew its stake in Doximity by 104.0% during the first quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after buying an additional 287 shares in the last quarter. Spire Wealth Management boosted its stake in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares in the last quarter. Optimum Investment Advisors acquired a new stake in shares of Doximity in the 4th quarter valued at approximately $43,000. Kapitalo Investimentos Ltda acquired a new stake in shares of Doximity in the 4th quarter valued at approximately $50,000. Finally, Huntington National Bank boosted its stake in shares of Doximity by 1,440.8% in the 4th quarter. Huntington National Bank now owns 1,094 shares of the company's stock valued at $58,000 after purchasing an additional 1,023 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Doximity

In related news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $52.89, for a total value of $105,780.00. Following the completion of the sale, the director owned 16,618 shares of the company's stock, valued at approximately $878,926.02. This trade represents a 10.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director directly owned 6,360 shares of the company's stock, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 76,000 shares of company stock worth $4,400,970. 37.40% of the stock is owned by insiders.

Doximity Price Performance

Shares of NASDAQ:DOCS traded down $1.53 during mid-day trading on Friday, hitting $60.07. The company had a trading volume of 1,733,558 shares, compared to its average volume of 2,181,248. The firm has a fifty day moving average price of $57.45 and a 200 day moving average price of $59.31. The company has a market capitalization of $11.28 billion, a PE ratio of 60.07, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a one year low of $25.00 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's revenue for the quarter was up 17.1% on a year-over-year basis. During the same period last year, the company posted $0.25 earnings per share. Research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DOCS has been the topic of a number of research analyst reports. Needham & Company LLC reduced their price target on shares of Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research note on Friday, May 16th. Evercore ISI upgraded shares of Doximity from an "in-line" rating to an "outperform" rating and raised their price target for the company from $50.00 to $70.00 in a research note on Wednesday, July 9th. Mizuho reduced their price target on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research note on Friday, May 16th. KeyCorp raised their price target on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research note on Monday. Finally, The Goldman Sachs Group set a $50.00 price target on shares of Doximity and gave the company a "neutral" rating in a research note on Wednesday, May 21st. Ten analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $64.89.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.